price target
-
Financial
Analysts Set ConforMIS Inc (NASDAQ:CFMS) Price Target at $23.00
Posted by mitch on Apr 14th, 2016 ConforMIS Inc (NASDAQ:CFMS) has been given an average rating of “Buy” by…
Read More » -
Financial
Oppenheimer Weighs in on Zimmer Biomet Holdings’ FY2015 Earnings (ZBH)
By Faye Duncan Oppenheimer boosted their FY2015 EPS estimates for shares of Zimmer Biomet Holdings (NYSE:ZBH) in a note issued…
Read More » -
Financial
Analyst Price Target Update on Alphatec Holdings, Inc. (NASDAQ:ATEC)
Alphatec Holdings, Inc. (NASDAQ:ATEC): The mean short term price target for Alphatec Holdings, Inc. (NASDAQ:ATEC) has been established at $2.5…
Read More » -
Financial
Tornier N.V. (NASDAQ:TRNX) Price Target Update
Tornier N.V. (NASDAQ:TRNX): 4 analysts have set the short term price target of Tornier N.V. (NASDAQ:TRNX) at $28.5. The standard…
Read More » -
Financial
CONMED CORPORATION (NASDAQ:CNMD) GIVEN RATING OF 2.29 BY ANALYSTS
CONMED Corporation (NASDAQ:CNMD) shares have been an average broker rating (ABR) of 2.29 at Zacks Research. This is based on…
Read More » -
Financial
Oppenheimer: Time To Buy ConforMIS, Two Catalysts Are Coming Next Year Read more
By Monica Gerson In a report published Monday, Oppenheimer analyst Steven Lichtman initiated coverage of ConforMIS Inc CFMS 4.79% with an Outperform rating…
Read More » -
Financial
Barclays Reiterates “Overweight” Rating for Smith & Nephew plc (SN)
By Robert Jamerson Smith & Nephew plc (LON:SN)‘s stock had its “overweight” rating reissued by analysts at Barclays in a research report…
Read More » -
Financial
Analyst: ConMed ripe for M&A spree
By Fink Densford ConMed could be poised for some merger & acquisition activity as new management engineers a turnaround, according…
Read More » -
Financial
CONMED Given New $64.00 Price Target at Leerink Swann (CNMD)
CONMED (NASDAQ:CNMD) had its price target upped by Leerink Swann from $60.00 to $64.00 in a research note issued to investors on Tuesday.…
Read More » -
Financial
CONMED Coverage Initiated at Northland Securities (CNMD)
By Mark Watkins Research analysts at Northland Securities initiated coverage on shares of CONMED (NASDAQ:CNMD) in a report released on…
Read More » -
Financial
Tornier NV Receives $25.75 Average Price Target from Analysts (NASDAQ:TRNX)
By Matt Cooper Shares of Tornier NV (NASDAQ:TRNX) have earned an average rating of “Hold” from the nine analysts that…
Read More » -
Financial
Histogenics Corp Stock Rating Lowered by Zacks (HSGX)
By Karim Khaledi Histogenics Corp (NASDAQ:HSGX) was downgraded by Zacks from a “hold” rating to a “sell” rating in a report released on…
Read More » -
Financial
CONMED Director Stephen Mandia Sells 3,899 Shares (CNMD)
CONMED (NASDAQ:CNMD) Director Stephen Mandia sold 3,899 shares of CONMED stock in a transaction that occurred on Thursday, April 30th. The shares were…
Read More »